Gary Taylor
Stock Analyst at TD Cowen
(0.51)
# 4,397
Out of 5,119 analysts
262
Total ratings
44.6%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Reiterated: Hold | $6 → $110 | $113.39 | -2.99% | 11 | Nov 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $26 → $31 | $24.42 | +26.95% | 8 | Nov 6, 2026 | |
| ALHC Alignment Healthcare | Rated: Buy | $8 → $10 | $7.34 | +36.24% | 7 | Nov 2, 2026 | |
| ACHC Acadia Healthcare Company | Rated: Buy | $91 → $24 | $37.00 | -35.14% | 14 | Feb 26, 2026 | |
| DVA DaVita | Reiterated: Hold | $139 → $157 | $191.35 | n/a | 26 | May 19, 2025 | |
| ELV Elevance Health | Reiterated: Buy | $589 | $425.62 | n/a | 15 | Oct 16, 2024 | |
| UNH UnitedHealth Group | Reiterated: Buy | $601 | $394.15 | n/a | 16 | Oct 11, 2024 | |
| SGRY Surgery Partners | Reiterated: Buy | $36 | $23.20 | n/a | 8 | Aug 1, 2024 | |
| CI The Cigna Group | Reiterated: Buy | $400 | $293.59 | n/a | 12 | Jul 29, 2024 | |
| HCA HCA Healthcare | Reiterated: Buy | $371 → $360 | $494.99 | n/a | 21 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $453 → $412 | $208.99 | n/a | 14 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $181 → $183 | $195.50 | n/a | 21 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $427 → $396 | $433.74 | n/a | 19 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $8.5 | $13.77 | n/a | 8 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $91 | $69.74 | n/a | 12 | Feb 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $4.00 | n/a | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 → $6 | $30.65 | n/a | 4 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1.75 | $4.82 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7 | $8.97 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $31.65 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $32 → $20 | $283.33 | n/a | 7 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $20 | $31.29 | n/a | 5 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.21 | n/a | 9 | Dec 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $74 | $255.63 | n/a | 4 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $114 → $132 | $366.57 | n/a | 4 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Nov 2, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $49.38 | n/a | 1 | May 11, 2009 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $21.02 | n/a | 1 | Jan 27, 2009 |
agilon health
Nov 6, 2026
Reiterated: Hold
Price Target: $6 → $110
Current: $113.39
Upside: -2.99%
Privia Health Group
Nov 6, 2026
Reiterated: Buy
Price Target: $26 → $31
Current: $24.42
Upside: +26.95%
Alignment Healthcare
Nov 2, 2026
Rated: Buy
Price Target: $8 → $10
Current: $7.34
Upside: +36.24%
Acadia Healthcare Company
Feb 26, 2026
Rated: Buy
Price Target: $91 → $24
Current: $37.00
Upside: -35.14%
DaVita
May 19, 2025
Reiterated: Hold
Price Target: $139 → $157
Current: $191.35
Upside: n/a
Elevance Health
Oct 16, 2024
Reiterated: Buy
Price Target: $589
Current: $425.62
Upside: n/a
UnitedHealth Group
Oct 11, 2024
Reiterated: Buy
Price Target: $601
Current: $394.15
Upside: n/a
Surgery Partners
Aug 1, 2024
Reiterated: Buy
Price Target: $36
Current: $23.20
Upside: n/a
The Cigna Group
Jul 29, 2024
Reiterated: Buy
Price Target: $400
Current: $293.59
Upside: n/a
HCA Healthcare
Apr 30, 2024
Reiterated: Buy
Price Target: $371 → $360
Current: $494.99
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $453 → $412
Current: $208.99
Upside: n/a
Apr 30, 2024
Reiterated: Hold
Price Target: $181 → $183
Current: $195.50
Upside: n/a
Apr 2, 2024
Reiterated: Buy
Price Target: $427 → $396
Current: $433.74
Upside: n/a
Mar 1, 2024
Rated: Hold
Price Target: $6 → $8.5
Current: $13.77
Upside: n/a
Feb 12, 2024
Reiterated: Buy
Price Target: $84 → $91
Current: $69.74
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5
Current: $4.00
Upside: n/a
Feb 13, 2023
Rated: Hold
Price Target: $3 → $6
Current: $30.65
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $3 → $1.75
Current: $4.82
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $6 → $7
Current: $8.97
Upside: n/a
Jan 11, 2021
Initiated Coverage: Buy
Price Target: $21
Current: $31.65
Upside: n/a
Sep 21, 2020
Downgraded: Sell
Price Target: $32 → $20
Current: $283.33
Upside: n/a
Feb 24, 2020
Reiterated: Hold
Price Target: $55 → $20
Current: $31.29
Upside: n/a
Dec 14, 2017
Downgraded: Sell
Price Target: n/a
Current: $2.21
Upside: n/a
Jan 30, 2015
Reiterated: Hold
Price Target: $65 → $74
Current: $255.63
Upside: n/a
Jan 5, 2015
Rated: Buy
Price Target: $114 → $132
Current: $366.57
Upside: n/a
Nov 2, 2010
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
May 11, 2009
Upgraded: Buy
Price Target: n/a
Current: $49.38
Upside: n/a
Jan 27, 2009
Upgraded: Buy
Price Target: n/a
Current: $21.02
Upside: n/a